Research Overview: Cardarine 10mg Sterling Knight
Cardarine (GW-501516) is a peroxisome proliferator-activated receptor delta (PPARδ) agonist originally developed for metabolic research studies. This synthetic compound has garnered significant attention in laboratory settings for its unique molecular mechanisms affecting cellular energy metabolism. Sterling Knight’s 10mg formulation provides researchers with precisely dosed capsules for consistent experimental protocols. The compound’s molecular structure allows for selective activation of PPARδ pathways, making it valuable for investigating metabolic processes in controlled laboratory environments.
Research institutions studying metabolic disorders often utilise Cardarine in their experimental protocols due to its selective receptor binding properties. The standardised 10mg dosing eliminates variability in research applications, ensuring reproducible results across multiple studies. Scientists at Stroid UK Shop facilities have access to comprehensive documentation supporting the compound’s research applications in cellular metabolism investigations.
Laboratory Applications and Research Protocols
Current research applications focus on Cardarine’s interaction with PPARδ receptors in cellular energy production pathways. Laboratory studies examine how the compound influences fatty acid oxidation processes at the molecular level. Researchers investigating metabolic syndrome utilise Cardarine in controlled studies examining cellular energy utilisation mechanisms. The compound’s selective receptor activation provides valuable insights into peroxisome proliferator pathways.
Academic institutions studying mitochondrial function often incorporate Cardarine into their research protocols. The 10mg capsule format allows for precise experimental dosing across multiple research phases. Studies examining cellular adaptation mechanisms frequently utilise this compound for investigating metabolic flexibility in laboratory models. Researchers specialising in SARMs research find Cardarine particularly useful for comparative metabolic studies.
Specifications and Research Grade Standards
| Property | Specification |
|---|---|
| Active Compound | GW-501516 (Cardarine) |
| Strength per Capsule | 10mg |
| Molecular Formula | C21H18F3NO3S2 |
| CAS Number | 317318-70-0 |
| Molecular Weight | 453.5 g/mol |
| Storage Temperature | Room temperature, dry conditions |
Laboratory researchers studying metabolic pathways often require compounds with verified purity standards. Sterling Knight maintains rigorous quality control protocols ensuring consistent compound integrity across production batches. Research facilities studying selective androgen receptor modulators benefit from standardised capsule formulations that eliminate measurement variability.
Comparative studies with peptide research compounds often utilise Cardarine as a metabolic pathway control in experimental designs.
Research Compliance and Laboratory Use
This product is manufactured exclusively for in-vitro research applications and is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All studies should be conducted in accordance with institutional research guidelines and applicable regulatory frameworks governing research chemical usage.
